RA MEDICAL SYSTEMS INC (RMED) Forecast, Price Target & Analyst Ratings
NYSEARCA:RMED • US74933X3026
0.594 USD
+0.05 (+10%)
At close: Aug 17, 2023
0.5785 USD
-0.02 (-2.61%)
After Hours: 8/17/2023, 8:04:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RA MEDICAL SYSTEMS INC (RMED).
Forecast Snapshot
Consensus Price Target
$7.14
+ 1,102.02% Upside
Next Earnings Forecast
Release DateNov 13, 2023
PeriodQ2 / 2023
EPS Estimate-$0.31
Revenue Estimate214.2K
ChartMill Buy Consensus
85.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$7.14
Upside
+ 1,102.02%
From current price of $0.59 to mean target of $7.14, Based on 7 analyst forecasts
Low
$7.07
Median
$7.14
High
$7.35
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
RMED was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about RMED.
In the previous month the buy percentage consensus was at a similar level.
RMED was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-10-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-03-17 | Maxim Group | Downgrade | Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 13, 2023
PeriodQ2 / 2023
EPS Estimate-$0.31
Revenue Estimate214.2K
Revenue Q2Q4,184.00%
EPS Q2Q97.72%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
RMED is expected to report earnings on 11/13/2023. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 214.20K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 259K -79.65% | 22K -91.51% | 14K -36.36% | 1.969M 13,964.29% | 8.813M 347.59% | 21.287M 141.54% | |
| EBITDA YoY % growth | -33.031M 35.05% | -27.701M 16.14% | -22.368M 19.25% | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.401M 32.71% | -29.266M 17.33% | -22.789M 22.13% | -72.726M -219.13% | -3.305M 95.46% | 4.121M 224.70% | |
| Operating Margin | -13,668.34% | -133,027.27% | -162,778.57% | -3,693.55% | -37.50% | 19.36% | |
| EPS YoY % growth | -1,580.50 70.87% | N/A 87.69% | N/A | -12.25 | -0.32 97.42% | 0.30 193.55% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 97.72% | -0.23 94.62% | -0.17 | -0.13 99.46% | -0.12 60.26% | -0.07 69.57% | -0.01 94.12% | 0.05 138.46% | 0.02 116.67% | 0.08 214.29% | 0.14 1,500.00% |
| Revenue Q2Q % growth | 214.2K 4,184.00% | 693.6K | 979.2K | 1.479M 1,640.00% | 1.673M 681.05% | 2.429M 250.20% | 3.232M 230.07% | 4.641M 213.79% | 4.264M 154.87% | 5.59M 130.14% | 6.793M 110.18% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.846M 62.57% | -1.652M 61.04% | -1.408M 82.65% | -1.163M 88.82% | -1.193M 35.36% | -795.6K 51.85% | -163.2K 88.41% | 724.2K 162.28% | 285.6K 123.93% | 1.081M 235.87% | 2.03M 1,343.87% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
26.23%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
1,049.91%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
RA MEDICAL SYSTEMS INC / RMED Forecast FAQ
What do analysts expect the price target to be for RA MEDICAL SYSTEMS INC (RMED)?
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
What is the next earnings date for RMED stock?
RA MEDICAL SYSTEMS INC (RMED) will report earnings on 2023-11-13.
What are the consensus estimates for RA MEDICAL SYSTEMS INC (RMED) next earnings?
The consensus EPS estimate for the next earnings of RA MEDICAL SYSTEMS INC (RMED) is -0.31 USD and the consensus revenue estimate is 214.20K USD.
What is the number of analysts for RMED stock?
The number of analysts covering RA MEDICAL SYSTEMS INC (RMED) is 7.